HiPP Dutch Stage 2 Combiotic Follow-on Milk Formula
Published August 25, 2021 · Recall initiated: August 8, 2021
Summary
FDA records food Class II recall F-0911-2021, published August 25, 2021 and initiated August 8, 2021. Recalling firm: Able Groupe Inc; Status: Terminated; Reported quantity: 76,000 units total; Lot: All codes. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The required pre-market notifications for these new infant formulas have not been submitted to the FDA. All products are not labeled as required by 21 CFR 107 .10 and 107.20 and do not bear mandatory labeling statements in English.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Able Groupe Inc
- Distributor
- All sales are direct from firm website - littlebundle.com
- Lot
- All codes
- Risk classification
- Class II
- Area (FDA)
- food
- Country
- United States
Related recalls
- FDAHiPP HA Germany Hypoallergenic Stage 1 Combiotic Infant Milk FormulaAugust 25, 2021
- FDAHolle Goat Stage 1 Organic Infant Milk FormulaAugust 25, 2021
- FDAHiPP Comfort Milk FormulaAugust 25, 2021
- FDALebenswert Anfangsmilch Stage 1 Organic Infant Milk FormulaAugust 25, 2021
- FDAHiPP HA Germany Hypoallergenic Stage PRE Combiotic Infant Milk FormulaAugust 25, 2021
- FDAHiPP Dutch Stage 1 Combiotic Infant Milk FormulaAugust 25, 2021
Questions about this recall
Was HiPP Dutch Stage 2 Combiotic Follow-on Milk Formula recalled?
Yes. FDA published recall F-0911-2021 on August 25, 2021. Reported hazard: The required pre-market notifications for these new infant formulas have not been submitted to the FDA. All products are not labeled as required by 21 CFR 107 .10 and 107.20 and do not bear mandatory labeling statements in English.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit